Interstitial Lung Diseases in Developing Countries

More than 100 different conditions are grouped under the term interstitial lung disease (ILD). A diagnosis of an ILD primarily relies on a combination of clinical, radiological, and pathological criteria, which should be evaluated by a multidisciplinary team of specialists. Multiple factors, such as...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pilar Rivera-Ortega, Maria Molina-Molina
Formato:	article
Lenguaje:	EN
Publicado:	Ubiquity Press 2019
Materias:	Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/35448d8e33104ef289ebbe7b2cc7ff31
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:35448d8e33104ef289ebbe7b2cc7ff31
record_format	dspace
spelling	oai:doaj.org-article:35448d8e33104ef289ebbe7b2cc7ff312021-12-02T04:13:02ZInterstitial Lung Diseases in Developing Countries2214-999610.5334/aogh.2414https://doaj.org/article/35448d8e33104ef289ebbe7b2cc7ff312019-01-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/2414https://doaj.org/toc/2214-9996More than 100 different conditions are grouped under the term interstitial lung disease (ILD). A diagnosis of an ILD primarily relies on a combination of clinical, radiological, and pathological criteria, which should be evaluated by a multidisciplinary team of specialists. Multiple factors, such as environmental and occupational exposures, infections, drugs, radiation, and genetic predisposition have been implicated in the pathogenesis of these conditions. Asbestosis and other pneumoconiosis, hypersensitivity pneumonitis (HP), chronic beryllium disease, and smoking-related ILD are specifically linked to inhalational exposure of environmental agents. The recent Global Burden of Disease Study reported that ILD rank 40th in relation to global years of life lost in 2013, which represents an increase of 86% compared to 1990. Idiopathic pulmonary fibrosis (IPF) is the prototype of fibrotic ILD. A recent study from the United States reported that the incidence and prevalence of IPF are 14.6 per 100,000 person-years and 58.7 per 100,000 persons, respectively. These data suggests that, in large populated areas such as Brazil, Russia, India, and China (the BRIC region), there may be approximately 2 million people living with IPF. However, studies from South America found much lower rates (0.4–1.2 cases per 100,000 per year). Limited access to high-resolution computed tomography and spirometry or to multidisciplinary teams for accurate diagnosis and optimal treatment are common challenges to the management of ILD in developing countries.Pilar Rivera-OrtegaMaria Molina-MolinaUbiquity PressarticleInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 85, Iss 1 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270
spellingShingle	Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270 Pilar Rivera-Ortega Maria Molina-Molina Interstitial Lung Diseases in Developing Countries
description	More than 100 different conditions are grouped under the term interstitial lung disease (ILD). A diagnosis of an ILD primarily relies on a combination of clinical, radiological, and pathological criteria, which should be evaluated by a multidisciplinary team of specialists. Multiple factors, such as environmental and occupational exposures, infections, drugs, radiation, and genetic predisposition have been implicated in the pathogenesis of these conditions. Asbestosis and other pneumoconiosis, hypersensitivity pneumonitis (HP), chronic beryllium disease, and smoking-related ILD are specifically linked to inhalational exposure of environmental agents. The recent Global Burden of Disease Study reported that ILD rank 40th in relation to global years of life lost in 2013, which represents an increase of 86% compared to 1990. Idiopathic pulmonary fibrosis (IPF) is the prototype of fibrotic ILD. A recent study from the United States reported that the incidence and prevalence of IPF are 14.6 per 100,000 person-years and 58.7 per 100,000 persons, respectively. These data suggests that, in large populated areas such as Brazil, Russia, India, and China (the BRIC region), there may be approximately 2 million people living with IPF. However, studies from South America found much lower rates (0.4–1.2 cases per 100,000 per year). Limited access to high-resolution computed tomography and spirometry or to multidisciplinary teams for accurate diagnosis and optimal treatment are common challenges to the management of ILD in developing countries.
format	article
author	Pilar Rivera-Ortega Maria Molina-Molina
author_facet	Pilar Rivera-Ortega Maria Molina-Molina
author_sort	Pilar Rivera-Ortega
title	Interstitial Lung Diseases in Developing Countries
title_short	Interstitial Lung Diseases in Developing Countries
title_full	Interstitial Lung Diseases in Developing Countries
title_fullStr	Interstitial Lung Diseases in Developing Countries
title_full_unstemmed	Interstitial Lung Diseases in Developing Countries
title_sort	interstitial lung diseases in developing countries
publisher	Ubiquity Press
publishDate	2019
url	https://doaj.org/article/35448d8e33104ef289ebbe7b2cc7ff31
work_keys_str_mv	AT pilarriveraortega interstitiallungdiseasesindevelopingcountries AT mariamolinamolina interstitiallungdiseasesindevelopingcountries
_version_	1718401359921807360

Interstitial Lung Diseases in Developing Countries

Ejemplares similares